MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$6.55 USD
+0.29 (4.63%)
Updated Aug 19, 2024 04:00 PM ET
After-Market: $6.55 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.55 USD
+0.29 (4.63%)
Updated Aug 19, 2024 04:00 PM ET
After-Market: $6.55 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session
by Zacks Equity Research
MiMedx Group (MDXG) shares rose more than 11% in the last trading session, amid huge volumes.
Are Options Traders Betting on a Big Move in MiMedx Group (MDXG) Stock?
by Zacks Equity Research
Surging implied volatility makes MiMedx Group (MDXG) stock lucrative to the option traders.
MiMedx Group (MDXG) Looks Good: Stock Adds 5.4% in Session
by Zacks Equity Research
MiMedx Group (MDXG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
MiMedx Group (MDXG) in Focus: Stock Moves 6.1% Higher
by Zacks Equity Research
MiMedx Group (MDXG) was a big mover last session, as the company saw its rise over 6% on the day amid huge volumes.
MiMedx Group (MDXG) Catches Eye: Stock Jumps 8.5% in Session
by Zacks Equity Research
MiMedx Group, Inc. (MDXG) moved big last session, as its shares rose above 8% on the day.
Falling Earnings Estimates Signal Weakness Ahead for MiMedx Group (MDXG)
by Zacks Equity Research
MiMedx Group (MDXG) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.
Why MiMedx Group (MDXG) Could Be Positioned for a Slump
by Zacks Equity Research
While MiMedx Group (MDXG) may not be a good pick right now, you can consider other stocks in the same industry.
Can MiMedx (MDXG) Double Despite FDA Investigation?
by David Bartosiak
Momentum Strategist David Bartosiak discusses MiMedx (MDXG) and the FDA investigation.